A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax

被引:41
作者
Brodszki, Nicholas [1 ]
Lansberg, John-Kalle [1 ]
Dictor, Michael [2 ]
Gyllstedt, Erik [3 ]
Ewers, Sven-Borje [4 ]
Larsson, Marcus K. [1 ]
Eklund, Erik A. [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Paediat Sect, BUT Team, Lund 22184, Sweden
[2] Lund Univ, Dept Clin Sci, Sect Pathol, Lund 22184, Sweden
[3] Lund Univ, Dept Clin Sci, Thorac Surg Sect, Lund 22184, Sweden
[4] Lund Univ, Dept Clin Sci, Sect Oncol, Lund 22184, Sweden
关键词
Acute respiratory failure; Alpha-interferon therapy; Heparin; PROTEIN-LOSING ENTEROPATHY; ENDOTHELIAL GROWTH-FACTOR; HEPARIN-BINDING PROTEIN; MASSIVE OSTEOLYSIS; DIFFUSE LYMPHANGIOMATOSIS; THERAPY; BONE; INTERFERON-ALPHA-2B; MECHANISMS; SULFATE;
D O I
10.1111/j.1651-2227.2011.02361.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To expand the treatment options in paediatric Gorham-Stout syndrome (GSS) when conventional therapy is ineffective. Method: Two children with biopsy confirmed GSS, a rare disorder with progressive lymphangiomatosis, were treated with a combination of interferon-alpha-2b, low anticoagulant, low molecular weight heparin, radiotherapy and surgery. Results: The combined therapy resolved the symptoms in the acute phase, and both patients have since been free of symptoms for >2 years. Conclusion: The successful addition of a low anticoagulant, low molecular weight heparin ( tafoxiparin) to the treatment protocol in two paediatric cases of the GSS may justify the use of this approach in similar cases.
引用
收藏
页码:1448 / 1453
页数:6
相关论文
共 30 条
[1]   Angiomatosis of bone and soft tissue: A spectrum of disease from diffuse lymphangiomatosis to vanishing bone disease in young patients [J].
Aviv, RI ;
McHugh, K ;
Hunt, J .
CLINICAL RADIOLOGY, 2001, 56 (03) :184-190
[2]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]   Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy [J].
Bode, L ;
Eklund, EA ;
Murch, S ;
Freeze, HH .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (05) :G1015-G1023
[4]   Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function [J].
Bode, Lars ;
Salvestrini, Camilla ;
Park, Pyong Woo ;
Li, Jin-Ping ;
Esko, Jeffrey D. ;
Yamaguchi, Yu ;
Murch, Simon ;
Freeze, Hudson H. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :229-238
[5]   VEGF in biological control [J].
Breen, Ellen C. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (06) :1358-1367
[6]   Lymphangiogenesis: in vitro and in vivo models [J].
Bruyere, Francoise ;
Noel, Agnes .
FASEB JOURNAL, 2010, 24 (01) :8-21
[7]   Inhibitory effect of interferon-α-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice [J].
Cao, Bin ;
Chen, Xiao-Ping ;
Zhu, Peng ;
Ding, Lei ;
Guan, Jian ;
Shi, Zuo-Liang .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (44) :6802-6807
[8]   Structure and biological interactions of heparin and heparan sulfate [J].
Casu, B ;
Lindahl, U .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 :159-206
[9]   Gorham-Stout syndrome: A monocyte-mediated cytokine propelled disease [J].
Colucci, S ;
Taraboletti, G ;
Primo, L ;
Viale, A ;
Roca, C ;
Valdembri, D ;
Geuna, M ;
Pagano, M ;
Grano, M ;
Pogrel, AM ;
Harris, AL ;
Athanasou, NN ;
Mantovani, A ;
Zallone, A ;
Bussolino, F .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) :207-218
[10]   Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease [J].
Devlin, RD ;
Bone, HG ;
Roodman, GD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1893-1897